BSEMBioStem Technologies, Inc.同业对比
BioStem Technologies, Inc. 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSEM本股 | — | — | — | — | — | — | — | — | — | — | — | — |
| ALVOW | $100M#6 | — | — | 0.2x#1 | 19.7%#5 | 112.0%#2 | 13.3%#3 | — | — | — | -74.6%#7 | — |
| APTN | — | — | — | — | — | -65.5%#10 | — | — | — | — | — | — |
| APTOF | — | — | — | — | — | -0.1%#8 | — | — | — | — | — | — |
| ARGX | $53.5B#1 | — | — | 1506.5x#4 | 254.4%#2 | 55.1%#3 | 2965.7%#1 | — | — | — | 29.2%#3 | — |
| AUTL | $562M#3 | — | 5.2x#2 | 7.4x#3 | 644.9%#1 | -30.3%#9 | -358.9%#5 | -264.2%#3 | — | — | -10.2%#5 | — |
| BNTX | $23.5B#2 | — | — | — | — | — | — | — | — | — | -15.9%#6 | — |
| CGEN | $228M#4 | 6.3x#1 | 2.2x#1 | 3.1x#2 | 161.1%#3 | 348.4%#1 | 43.1%#2 | 34.4%#1 | — | — | 65.1%#1 | — |
| CKDXF | — | — | — | — | -80.0%#6 | 26.1%#4 | -623048.0%#7 | — | — | — | — | — |
| CLDWW | — | — | — | — | — | 10.1%#7 | -44977.8%#6 | -403.4%#4 | — | — | — | — |
| CLLS | — | — | — | — | 75.8%#4 | -83.9%#11 | -45.3%#4 | -89.1%#2 | — | — | 8.4%#4 | — |
| CPMV | — | — | — | — | — | 25.4%#6 | — | — | — | — | — | — |
| CRDL | $142M#5 | — | — | — | — | — | — | — | — | — | 30.4%#2 | — |
| CYVNY | — | — | — | — | -80.0%#6 | 26.1%#4 | -623048.0%#7 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-09。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议